Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This randomized, open label, controlled, parallel group study is designed to test whether
2-day high dose atorvastatin administration before PCI and 30-day continuous intensive
atorvastatin treatment is superior to usual care, in terms of peri-PCI cardiovascular events,
as well as 6-month prognosis. The goal is to set up an optimized protocol for peri-PCI statin
treatment in Chinese CHD patients. Safety will also be observed.